Form 4: VolitionRx CEO Cameron Reynolds Boosts Stake with $7,372 Stock Purchase

VolitionRx Ltd.'s President and CEO, Cameron John Reynolds, increased his direct beneficial ownership by purchasing 12,500 shares of common stock at $0.5898 per share.

Summary

• Cameron John Reynolds, President and CEO, Director, and 10% Owner of VolitionRx Ltd. (VNRX), purchased 12,500 shares of the company's common stock.
• The transaction occurred on June 12, 2025, at a price of $0.5898 per share, totaling approximately $7,372.50.
• Following this transaction, Mr. Reynolds directly beneficially owns 2,331,722 shares of common stock.
• He also indirectly beneficially owns 1,007,718 shares through Concord International, Inc., where he is the majority shareholder, and 34,076 shares through his spouse, bringing his total beneficial ownership to 3,373,516 shares.
• The transaction was made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 8

Explanation: The purchase of shares by the CEO, who is also a Director and 10% owner, is a strong positive signal of confidence in the company's future prospects and valuation.

Positives

• Insider buying by a key executive (President and CEO, Director, and 10% Owner) signals confidence in the company's future prospects.
• The purchase increases the CEO's direct stake, aligning his interests further with shareholders.

Future Outlook

NA

Industry Context

Insider purchases, especially by top executives like the CEO, are generally viewed positively by the market as they indicate management's belief in the company's undervaluation or strong future performance, which can influence investor sentiment within the biotechnology or diagnostics industry where VolitionRx operates.

Comparison to Industry Standards

• Insider buying by a CEO is a strong signal of confidence, often outperforming general market sentiment.
• While specific comparable companies or projects are not detailed in this filing, such a transaction by a key insider like Cameron John Reynolds, who also holds a significant 10% ownership, is typically interpreted as a bullish indicator, aligning with best practices for management demonstrating commitment to shareholder value.

Related Party Transactions

• The transaction involves Cameron John Reynolds, the President and CEO, Director, and 10% owner, purchasing shares directly.
• Additionally, he indirectly controls shares through Concord International, Inc., where he is the majority shareholder, making transactions involving these entities related party dealings.

Stakeholder Impact

• Shareholders: The insider purchase may instill confidence among existing and potential shareholders, potentially leading to increased demand for the stock.
• Employees: A confident management team can positively impact employee morale and stability.
• Creditors: Strong insider confidence might indirectly signal financial stability, which could be viewed favorably by creditors.

Key Dates

Recommendation

Keywords

VolitionRx, VNRX, SEC Form 4, Insider Trading, Stock Purchase, Cameron John Reynolds, CEO, Director, Beneficial Ownership, Equity, Securities, Rule 10b5-1